Merck Sharpe and Dohme has launched new formulations for all dosage strengths of its NSAID etoricoxib [Arcoxia]

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1538, 2006-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The WHO has launched a new HIV/AIDS package of priority interventions

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 560, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

A new campaign for better access to psychological therapies has been launched in the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 599, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Merck & Co., Inc. has lowered its prices in developing countries for its 2 HIV drugs

By  

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Merck & Co. has substantially cut the price of 2 of its antiretroviral agents in Mexico

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Three new MiniQuick formulations of Pfizer's somatropin [Genotropin] have been launched in Japan

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite